OkuStim 2 System

Uses

Dosage & preparation

Preparation

Background

Evidence quality

Highlighted claims

• The OkuStim 2 System is a class IIa medical device developed by Okuvision for minimally invasive electrical stimulation of the eye. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• The device is worn like glasses. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• The single-use OkuEl M thread electrode is placed on the ocular surface at the inferior limbus, with counter electrodes on the forehead. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• The stimulation waveform uses symmetric biphasic rectangular current pulses at 20 Hz, up to 1 mA. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• Patients cannot change the programmed therapy amplitude themselves. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• No direct preclinical animal studies were performed with the OkuStim 2 System due to technical constraints. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol